E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers I > Headlines for Integrated BioPharma, Inc. > News item
Published on 1/5/2012 in the Prospect News PIPE Daily.

Integrated BioPharma extends forbearance agreement for 8% notes

Agreement has been extended to Jan. 10, 2012 from Jan. 6, 2012

By Devika Patel

Knoxville, Tenn., Jan. 5 - Integrated BioPharma, Inc. extended its forbearance agreement for its 8% senior secured notes on Dec. 29, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The agreement has been extended to Jan. 10, 2012 from Jan. 6, 2012.

Integrated BioPharma is a pharmaceutical company based in Hillside, N.J.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.